Alpha-1 adrenergic receptor and Alpha-2 adrenergic receptor (α1-AR and α2-AR)

Alpha-1 adrenergic receptor and alpha-2 adrenergic receptor are two major subtypes of adrenergic receptors, members of the G protein-coupled receptor (GPCR) superfamily, that mediate physiological responses to the catecholamines epinephrine and norepinephrine[1][7]. Alpha-1 receptors are typically located on vascular smooth muscle, where activation causes vasoconstriction and increases blood pressure[7][4]. Alpha-2 receptors occur both presynaptically in the central and peripheral nervous system and postsynaptically; their activation reduces norepinephrine release and generally results in a lowering of sympathetic outflow, having antihypertensive and sedative effects[5][7]. Both receptors are widely targeted by therapeutic drugs used to manage cardiovascular, urological, and neuropsychiatric disorders; common agents include phenylephrine (α1 agonist), prazosin (α1 antagonist), clonidine (α2 agonist), and yohimbine (α2 antagonist)[3][5][6][9]. **Note:** The entry "Alpha-1 and Alpha-2 Adrenergic Receptors" combines two distinct target proteins; for precise structured data, these should each be covered separately in line with scientific conventions.

Other names

Alpha-adrenergic receptor (generic for both types)α1-adrenoceptor, α2-adrenoceptorAlpha-1 adrenoreceptor, Alpha-2 adrenoreceptor

α1 agonists: stimulate smooth muscle contraction, vasoconstriction. α1 antagonists: induce vasodilation and reduce peripheral vascular resistance. α2 agonists: activate presynaptic inhibitory receptors, reducing norepinephrine release, producing central sympatholytic effects (lowering blood pressure). α2 antagonists: increase central and peripheral norepinephrine release.